William J. Evans (529233)Kevin A. Miller (2102332)Stosh A. Kozimor (1615057)Joseph W. Ziller (1340067)Antonio G. DiPasquale (1274730)Arnold L. Rheingold (1274736)
Methods to separate the components of the equilibrium mixture of [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH]<sub>2</sub> and [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH<sub>2</sub>]<sub>2</sub> have been developed that allow their reductive chemistry to be studied. These actinide hydrides\ncan act as four-, six-, and eight-electron reductants depending on the substrate with H<sub>2</sub> as the byproduct\nof a H<sup>-</sup> → e<sup>-</sup> + <sup>1</sup>/<sub>2</sub> H<sub>2</sub> redox couple. This hydride reduction chemistry allows complexes of redox-inactive Th<sup>4+</sup> such as [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>ThH<sub>2</sub>]<sub>2</sub> to be four- and six-electron reductants. [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH]<sub>2</sub> and [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH<sub>2</sub>]<sub>2</sub> cleanly reduce 2 equiv of PhEEPh (E = S, Se) to form 2 equiv of (C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>U(SPh)<sub>2</sub> and\n(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>U(SePh)<sub>2</sub> in an overall four-electron reduction in each case. [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH]<sub>2</sub> and [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH<sub>2</sub>]<sub>2</sub> also effect a six-electron reduction of 3 equiv of 1,3,5,7-cyclooctatetraene to [(C<sub>5</sub>Me<sub>5</sub>)(C<sub>8</sub>H<sub>8</sub>)U]<sub>2</sub>(C<sub>8</sub>H<sub>8</sub>) and an eight-electron reduction of 2 equiv of PhNNPh to form 2 equiv of the U<sup>6+</sup> imido complex\n(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>U(NPh)<sub>2</sub>. In each reaction, H<sub>2</sub> is a byproduct. This hydride-based reduction is also successful\nwith the tetravalent thorium hydride [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>ThH<sub>2</sub>]<sub>2</sub>, which reduces 2 equiv of PhSSPh to (C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>Th(SPh)<sub>2</sub> and 3 equiv of C<sub>8</sub>H<sub>8</sub> to [(C<sub>5</sub>Me<sub>5</sub>)(C<sub>8</sub>H<sub>8</sub>)Th]<sub>2</sub>(C<sub>8</sub>H<sub>8</sub>) with concomitant formation of H<sub>2</sub>. X-ray\ncrystallographic data are reported on [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH]<sub>2</sub>, [(C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>UH<sub>2</sub>]<sub>2</sub>, and (C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>U(SePh)<sub>2</sub> as well as\nthe thorium reduction products (C<sub>5</sub>Me<sub>5</sub>)<sub>2</sub>Th(SPh)<sub>2</sub> and [(C<sub>5</sub>Me<sub>5</sub>)(C<sub>8</sub>H<sub>8</sub>)Th]<sub>2</sub>(C<sub>8</sub>H<sub>8</sub>).
David J. Berg (1887763)Richard A. Andersen (244546)
William J. Evans (529233)Justin R. Walensky (1472710)Filipp Furche (1277427)Joseph W. Ziller (1340067)Antonio G. DiPasquale (1274730)Arnold L. Rheingold (1274736)
H. Martin Dietrich (1983931)Joseph W. Ziller (1340067)Reiner Anwander (1367811)William J. Evans (529233)
William J. Evans (529233)Kevin A. Miller (2102332)Joseph W. Ziller (1340067)Antonio G. DiPasquale (1274730)Katie J. Heroux (1276398)Arnold L. Rheingold (1274736)
Evan L. Werkema (1782670)Ludovic Castro (1472713)Laurent Maron (1346082)Odile Eisenstein (1358145)Richard A. Andersen (244546)